[1] |
CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian.
Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
|
[2] |
LIU Lianlian, YU Huiyong, WANG Mingzhe, GUO Shanshan, LI Lei, GAO Yue, WEI Shixiang, KE Yinze, WANG Chengxiang.
TCM Medications for Pulmonary Nodules Based on Traditional Chinese Medicine Inheritance Assistance System
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 513-516.
|
[3] |
LI Can, LIU Lehuan, CHEN Xia, QU Jianbo.
Pharmacy of Chinese Medicine Compound Preparations Based on Human Experiences
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 564-569.
|
[4] |
LI Shuran, XIE Rui, ZHAO Ronghua, BAO Lei, GENG Zihan, SUN Qiyue, CUI Xiaolan, GUO Shanshan, SUN Jing.
Research Progress in the Pathogenesis and Medications of Trigeminal Neuralgia
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 596-600.
|
[5] |
GUO Dongqi, WANG Hao, BAI Xin, BAI Jianqi, SU Hongmei, ZHANG Jingru, GUO Xiaofei, ZHAO Xiaoqi, WANG Min, WANG Yuan, ZHANG Ping.
Identification of Druggable Targets for Intervertebral Disc Degeneration Based on Multi-Omics Data-Driven Mendelian Randomization and Prediction of Traditional Chinese Medicine Interventions
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 241-248.
|
[6] |
BAI Xin, WANG Min, WANG Yuan, BAI Jianqi, SU Shuang, LIU Guanghui, GUO Xiaofei, KANG Jiaqi, GUO Dongqi, ZHANG Yimeng, WANG Hao, ZHAO Xiaoqi, ZHANG Ping.
Traditional Chinese Medicine Used in the Treatment of Gout Complicated with Osteoarthritis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 258-262.
|
[7] |
JIA Zhichao, HU Siyuan, LI Ruiben, XU Yaqian.
Safety of Children’s Traditional Chinese Medicine Decoction Pieces in Clinical Application and Children’s Drug Development
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 324-328.
|
[8] |
LIANG Xiao, LI Li, XU Xiaolong, BAI Yinglu, YANG Yumei, ZHU Yong, LIU Qingquan.
Advancements in Treatment of Brucellosis with Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 231-234.
|
[9] |
SUN Li, XIE Bin, XU Yanqin.
Research progress of sustained and controlled release preparations of Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 949-954.
|
[10] |
SHAO Bo, GUO Xiaoxin.
Review of pharmacovigilance of traditional Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 741-745.
|
[11] |
LIU Yang, FAN Zheng, WANG Honglei, YANG Ying, GUO Qi, CHANG Xinyu, HAN Lijuan, LI Wenzhe, WU Jiankun.
Therapeutic effect of Jingzhui Kangfu pills against osteoarthritis induced by proteoglycan in mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 651-654.
|
[12] |
PAN Zhiyu, ZHU Jian, YU Yanan, LIU Jun, JIANG Yanhua, QIAN Zhenzhen, WU Guang, WANG Zhong, WU Hongli, JING Zhiwei.
A real-world safety study of 3 010 cases of Qizhitongluo capsule
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 660-665.
|
[13] |
LI Yao, CHEN Yuxin, GAO Haiyun, LI Hui, LIU Tianrui, YUAN Yuan.
Analysis of prescription rules for Omphalia lapidescens based on the Dictionary of Chinese Traditional Medicine Prescriptions
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 553-558.
|
[14] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[15] |
ZHANG Jian, FANG Huihua.
Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
|